View in EDS HTML Full Text PDF Full Text

Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report.

Saved in:

Bibliographic Details
Title:	Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report.
Authors:	Jing, Xuquan¹ (AUTHOR), Li, Li^1,2 (AUTHOR), Lu, Shuangqing¹ (AUTHOR), Zhai, Xiaoyang¹ (AUTHOR), Zhu, Hui¹ (AUTHOR) drzhuh@126.com
Source:	Oncology Letters. Jan2026, Vol. 31 Issue 1, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17921074
DOI:	10.3892/ol.2025.15385